The Drug Control Punjab has declared the medicine ‘Azomax’ as a counterfeit.
Punjab’s drug regulatory authorities have issued a Class-I alert after laboratory testing found four batches of a medicine to be counterfeit or substandard, prompting a market recall and enforcement action.
According to the Drugs Control Department, the affected products were allegedly being distributed by unauthorised suppliers while being presented as medicines manufactured by legitimate pharmaceutical companies.
Officials said preliminary laboratory analysis showed that the medicine failed to meet required pharmaceutical standards, leading authorities to classify the batches as counterfeit or substandard.
In response, regulators ordered the immediate recall of the affected batches, suspended their sale and launched inspections to recover any remaining stock from the market.
Health authorities have advised healthcare professionals, pharmacies and patients not to use suspected counterfeit supplies of Azomax and to report any questionable products to the relevant regulatory bodies.
Read more: Italy to offer 10,500 jobs for workers in Pakistan
The latest alert comes amid ongoing efforts to tackle counterfeit medicines in the province. Authorities noted that several other medicines, including Brexin, Danzen DS, Tonoflex-P and Novidat 500mg, had previously been identified as counterfeit and linked to unregistered distributors.
Officials said investigations were continuing and that further action would be taken against those involved in the distribution of counterfeit pharmaceutical products.
Also read: Hania Amir saying ‘Phir se bolo’ in Asim Azhar’s new song sparks social media debate
